Global Blood Glucose Monitoring Systems Market 2018-2024: Opportunities with New Collaboration and Funding to Develop New Devices
DUBLIN, Sept. 10, 2018 /PRNewswire/ --
The "Global Blood Glucose Monitoring Systems Market 2018-2024" report has been added to ResearchAndMarkets.com's offering.
The Global Blood Glucose Monitoring Systems market is estimated to witness a CAGR of 6.7% during the forecast period 2018-2024.
Blood glucose monitoring is an integral part of the standard diabetes care, and it is very helpful in controlling the glucose levels in individuals with diabetes and impaired glucose tolerance. The incidence of diabetes is increasing globally, and around 90% of the patients have type 2 diabetes mellitus with approximately one-fifth of the people undergoing insulin treatment. Self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems are two major types of blood glucose monitoring systems.
The market for blood glucose monitoring systems is driven by increasing incidence of diabetes across various geographies, huge surge in the aging population, and increasing product launch and approvals. Increasing collaboration and funding to develop innovative devices and raising awareness among the patients are providing an opportunity for the market growth. Product recalls and inadequate reimbursements are few of the factors that may hamper the market growth to an extent.
Scope of the Report
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the major shareholder in the global blood glucose monitoring systems market, followed by Europe. The Asia Pacific region is expected to grow at a high CAGR during the forecast period due to an upsurge in access to health care services, increasing patient pool, raising awareness among patients, and growing healthcare expenditure.
Product Analysis: The blood glucose monitoring systems market, by product, is segmented into self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems. SMBG systems occupied a significant market share in 2017, and CGM systems are expected to grow at a high CAGR during the forecast period. Increasing adoption of minimally invasive procedures makes it the fastest growing segment during the forecast period.
Application Analysis: The market, by applications, is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes occupied a significant market share in 2017 and is expected to remain the same for the next 5 years. This is due to growing patient base for type 2 diabetes and increasing launch of the advanced product in this segment.
End-users Analysis: The market, by end-users, is segmented into hospitals, homecare, private clinics, and others. Among various end-users, homecare occupied a significant market share and is expected to remain the same during the forecast period.
Competitive Analysis: The market has a large number of medium and small players that offer innovative products and has immense growth opportunity, especially in the emerging countries. The key market players are taking advantage of product approvals and new product launches, making their strategies to increase the market share. For instance, in September 2017, the US FDA approved FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip.
Key Topics Covered:
1 Industry Outlook
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition
3.2 Advantages of blood glucose monitoring systems
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the blood glucose monitoring systems market
3.5 Related Markets
3.5.1 Insulin pump
3.5.2 Smart insulin pen
3.5.3 Insulin Syringes
4 Market Outlook
4.1 Evolution of Blood Glucose Monitoring
4.2 Market segmentation
4.3 PEST Analysis
4.4 Porter 5(Five) Forces
5 Market Characteristics
5.1 DRO - Global Blood Glucose Monitoring Systems Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing incidence of diabetes across various geographies
5.1.1.2 Increasing number of product launch and approvals
5.1.1.3 Huge surge in the aging population
5.1.2 Opportunities
5.1.2.1 New collaboration and funding to develop new devices
5.1.2.2 Growing patient awareness
5.1.3 Restraints
5.1.3.1 High cost and inadequate reimbursement
5.1.3.2 Product recalls
5.2 DRO - Impact Analysis
5.3 Key Stakeholders
6 Products: Market Size & Analysis
6.1 Overview
6.2 Self-monitoring Blood Glucose Systems
6.3 Continuous Glucose Monitoring Systems
7 Application: Market Size & Analysis
7.1 Overview
7.2 Type 1 Diabetes
7.3 Type 2 Diabetes
7.4 Gestational Diabetes
8 End-User: Market Size & Analysis
8.1 Overview
8.2 Hospitals
8.3 Homecare
8.4 Private clinics
8.5 Others
9 Regions: Market Size and Analysis
10 Competitive Landscape
10.1 Overview
11 Vendor Profiles
11.1 Medtronic plc
11.2 Abbott Laboratories
11.3 Johnson and Johnson
11.4 F.Hoffmann-La Roche Ltd.
12 Companies to Watch for
12.1 Dexcom
12.2 PHC Holdings Corporation
12.3 Ypsomed Holding
12.4 B. Braun Melsungen AG
12.5 Trividia Health, Inc.
12.6 Acon Laboratories
12.7 Sanofi S.A.
12.8 Arkray, Inc.
12.9 Nova Biomedical Corporation
12.10 Prodigy Diabetes Care, LLC
12.11 Terumo Medical Corporation
For more information about this reportvisit
https://www.researchandmarkets.com/research/f8q7qp/global_blood?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article